March 27, 2018 : DCMS #390

DISASTERS AVERTED — Near Miss Case Studies

We Repeat: Teach To Remove The Needle Shield!

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Swapnil N. Rajpathak Part 2, Cost Effectiveness Of DPP-4 Inhibitors

HOMERUN SLIDES — Great Clinical Presentation Highlights

Hypertension Update 2018 Part 3

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #118: Diabetes and Sleep Apnea Part 8

MOST POPULAR ARTICLES OF THE MONTH

#1 SGLT2 Inhibitors in Treatment of Type 1
#2 A Summary of ADA’s New 2018 Standards of Medical Care in Diabetes
#3 American College of Physicians Recommending Controversial Increase in A1c of 7% to 8%

Over the past 2 months, we have shared information from our clinical textbook on the relationship of Diabetes and Obstructive Sleep Apnea. OSA is often left undiagnosed in diabetes patients and each of the two conditions can worsen the other. This week, we look at some of the other effects that the combination can have. I am not going to spoil the surprise of what one of them is, but let me just say that we may all be glad that there are self-driving cars on the horizon.

Dave Joffe

Editor-in-chief

Last week I was teaching a patient how to self inject an injectable medication. As I was going through the steps, I told her twice of the importance of removing not only the outer cover of the needle, but also the needle shield. She gave me one of those looks like, “Why did you tell me this twice?” Then she said, “I know!”

In part 2 of this Exclusive Interview, Dr. Swapnil N. Rajpathak talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the ultimate savings in the use of DPP4s — reduced risk of hypoglycemia.

In this week’s Homerun Slides, a closer look at the causes of hypertension with a special focus on Grave’s Disease.

Other OSA comorbidities: Road traffic accidents — Several cross-sectional studies using driving simulators showed worse driving performance and increased risk of road traffic accidents in patients with OSA. In a sample of 913 employed adults whose motor vehicle accident history was obtained from a statewide database covering the period 1988–1993, men with OSA were more likely to have at least one accident in 5 years compared to those without OSA.

Meta-analysis explores safety and efficacy of sodium-glucose co-transporter 2 inhibitors in patients with type 1 diabetes.

Comprehensive recommendations feature notable new recommendations for people with cardiovascular disease and diabetes.

Organization says adults with type 2 diabetes can aim for an easier-to-achieve blood sugar target than what’s been used to guide treatment in the past.